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An investigation of malaria in a US patient without
recent travel established Plasmodium falciparum molecular
genotype identity in 2 patients who shared a hospital room.
P. falciparum can be transmitted in a hospital environment
from patient to patient by blood inoculum if standard pre-
cautions are breached.
A
lmost all of the 1,400 cases of malaria reported each
year in the United States are acquired by mosquito
bite during travel in malaria-endemic areas (1). However,
mosquito transmission in the United States accounts for a
few cases each year (2). Nosocomial malaria represents
person-to-person transmission of parasite-infected erythro-
cytes through blood transfusion, needlestick injury,
improper use of blood glucometers, multidose heparin
vials, organ transplantation, contaminated catheters that
deliver contrast medium, or rarely, open wounds (3–6).
Nosocomial transmission of malaria secondary to inpa-
tient nursing practices has never been reported in the
United States. We report nosocomial transmission of
Plasmodium falciparum, confirmed by molecular genotyp-
ing, by improper use of saline flush syringes in a tertiary
care hospital in the United States. 
The Study
Abdominal pain, emesis, and a high fever developed in
patient 1, a 9-year-old Gambian boy with sickle cell dis-
ease residing in the United States, during the flight home
after a month in the Gambia; he had taken no malaria pro-
phylaxis drugs. After diagnosis of P. falciparum malaria
with 4% parasitemia and transfer to unit Aof a tertiary care
hospital, he responded well to antimalarial therapy and
was discharged 2 days later.
Seven days before patient 1’s admission, patient 2, a
14-year-old girl, with severe developmental delay, was
admitted to unit Afor placement of a surgical feeding tube.
Patients 1 and 2 shared a unit A semiprivate room for ≈24
hours. Patient 1 received a continuous quinidine gluconate
infusion through a peripheral intravenous line. Chart
review and interviews indicated that neither patient had
glucose monitoring by glucometer, blood transfusions,
common infusions such as contrast material, or a needle-
stick injury report, all events that have been previously
implicated in nosocomial malaria. Medicine doses given
and blood samples drawn were documented with a separa-
tion time >50 minutes. Aweek after discharge and 17 days
after sharing the semiprivate room, patient 2 was admitted
to another hospital (3-day stay), and a viral illness was
diagnosed after all cultures were negative for pathogens.
Persistent fever and pancytopenia developed and resulted
in her readmission to unit A of the tertitary care hospital,
now 23 days after sharing the room with patient 1. Patient
2 was febrile and pale, with no notable change in her base-
line neurologic state. The leukocyte count was 1,890
cells/mm3, hematocrit was 35.2%, platelets were
47,000/mm3, and total bilirubin was 1.5 mg/dL. Despite
administration of antimicrobial drugs for presumed micro-
bial sepsis, the following conditions developed over the
next 72 hours: persistent spiking fevers; loose, nonbloody
stools; splenomegaly; abdominal distension; and bilateral
lower extremity edema. Formal review of her peripheral
blood smear by the hematology consultation service
showed intraerythrocytic ring forms indicative of P. falci-
parum malaria, with 12% parasitemia and ≈200 gameto-
cytes/mm3. After 3 blood transfusions and quinidine
gluconate and doxycycline therapy, the patient was dis-
charged on hospital day 14, with a stable hematocrit, per-
sistent gametocytemia, and splenomegaly. Initial and
follow up tests on patient 2 were negative for viral blood-
borne pathogens. The patient lives with her parents in the
Baltimore-Washington area ≈12 miles from the nearest
international airport. She had no history of recent travel to
any areas that are endemic for malaria. No locally acquired
cases of malaria had been reported in the regional area.
This prompted an investigation to look for a nosocomial
route of transmission. Approval for the study was obtained
from Johns Hopkins University 
Two potential sources of nosocomial transmission in
unit A were identified: 1) heparin syringes, which were
filled from multidose vials, and 2) factory preloaded 10-
mL saline flushes, of which up to 3 mL was used per flush
for intravenous lines not in use. Hospital policy had strict
guidelines for using multidose devices and did not allow
reusing single use devices. However, interviews of 7 nurs-
es, including those who cared for the 2 patients, showed
that 2 nurses admitted reusing saline flushes on the same
patient, and 4 nurses had observed saline flushes being
reused in unit A. Reusing multidose heparin vials was not
documented. 
To determine whether used saline flush syringes that
were visibly clear contained blood, we tested saline from 8
used syringes and 2 unused controls. The contents of only
1 used saline flush syringe visibly contained blood. After
the contents were centrifuged to concentrate erythrocytes,
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*Johns Hopkins University, Baltimore, Maryland, USAblood was found in 4 of 8 of the used syringes (Figure 1)
by using matrix-assisted laser desorption ionization/time-
of-flight mass spectrometry (7). No blood was found in the
unused syringes. 
Polymerase chain reaction (PCR) amplification of P.
falciparum genomic DNA, isolated with DNAzol
(Invitrogen, Carlsbad, CA, USA), was successful from the
archived Giemsa blood films from both patients and 2
other patients (not related in time or travel history) infect-
ed with P. falciparum malaria seen at our institution in the
past year. Figure 2 shows that the PCR product restriction
digests for the polymorphic P. falciparum merozoite pro-
tein 2 (Pfmsp2) (8) and the P. falciparum chloroquine
resistance transporter (Pfcrt) (9) gene fragments were
identical for patients 1 and 2. This identity was also con-
firmed by sequence analysis. 
We also examined 4 P. falciparum microsatellite alleles
(TA81, PFPK, C13M30, C4M8) at independent chromoso-
mal loci by a fluorescent-tagged heminested PCR amplifi-
cation (10). Patients 1 and 2 had identical Plasmodium
microsatellite lengths at all 4 loci; each of the positive con-
trols was different as shown in Figure 2, the online
Appendix Figure (available at http://www.cdc.gov/ncidod/
EID/vol11no07/05-0092_appG.htm), and the Table. With
the simplistic assumption of >10 alleles at each microsatel-
lite loci and Pfmsp2, the chance occurrence of identity is
<1:100,000. By using the AmpFLSTR Profiler kit
(Applied Biosystems, Foster City, CA, USA), subsequent
forensic analysis of the human genomic DNA from leuko-
cytes in the same isolated P. falciparum  DNA samples
from the blood films demonstrated the sex difference
between patients 1 and 2. The analysis also demonstrated
the differences at 9 human microsatellite loci, which indi-
cated that cross-contamination during processing was not
a likely source for the similarities detected.
Conclusions
Natural transmission of malaria between patients 1 and
2 by a mosquito is not possible within 24 hours; the matu-
ration cycle from ingestion of viable gametocytes in a
blood meal to infective sporozoite stage in the mosquito
salivary glands is 8–35 days (11). Direct mechanical trans-
mission of parasitized blood by an arthropod vector is a
theoretical possibility, but no such transmission has ever
been reported, and the female Anopheles mosquito does
not regurgitate blood upon refeeding. Another remote pos-
sibility, luggage malaria, is the introduction of an already
infectious mosquito from the Gambia brought into unit A
through patient 1’s luggage (12). If this were the case, a
different parasitic genotype would be expected in patients
1 and 2 because the wild mosquito that infected patient 1,
from 1 to 2 weeks before onset of symptoms, would have
died 2–6 days after delivering the infective bite. Likewise,
an asymptomatic traveling companion of patient 1 would
have a distinct parasite genotype. 
In this report, epidemiologic investigation excluded
many nosocomial routes of transmission. Potential sources
not excluded were multidose heparin vials and saline flush
syringes. However, identifying reuse of saline flush
syringes in the unit and detecting blood in clear, used
saline flush syringes suggested that this was the most like-
ly source. Finally, molecular identity of P. falciparum iso-
lated from patients 1 and 2, as assessed by restriction
fragment length polymorphism of Pfmsp2, and forensic
microsatellite analysis of P. falciparum genotypes con-
firmed that contaminated fluid from patient 1 was the
source of the infection in patient 2. Together, these data
strongly suggest that apparently clear solution in a used
DISPATCHES
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Figure 1. Mass spectroscopic analysis of sterile saline flush
syringes after routine use. The contents of the used syringes were
concentrated by centrifugation. Matrix-assisted laser desorption
ionization detected the α and β chains of hemoglobin as the ions
at mass/charge (m/z) 15,126 and 15,867, respectively, in samples
A (red), B (green), C (blue), and J (aqua) that were absent in the
matrix alone (black). The lower limit of sensitivity with matrix-
assisted laser desorption ionization is ≈0.5 erythrocytes per mL.
Figure 2. Genotype analysis of patient blood films. Restriction frag-
ment length polymorphism are shown for Pfmsp2 and  Pfcrt.
Patient 1 and 2 are identical at the polymorphic Pfmsp2 (lanes 1
and 2), while unrelated patient controls (lanes 3 and 4) are differ-
ent. One of the 2 negative controls is shown (lane 5). Genomic
DNA from clone HB3 (lane 6) and isolate NF54 (lane 7) are also
included as additional positive controls. All recent patient samples
have the Plasmodium falciparum chloroquine-resistant genotype.saline flush syringe containing infected P. falciparum ery-
throcytes, was reused on a neighboring patient, leading to
nosocomial transmission of malaria. Saline flush vials and
bags have been implicated in nosocomial transmission of
hepatitis B and microbes, respectively (13,14).
Theoretically, a single infected erythrocyte is able to
transmit malaria by inoculation. Patient 1 had almost 200
million infected erythrocytes per milliliter of blood based
on parasitemia level. Based on our data, apparently clear
saline can contain ≈1 million erythrocytes per milliliter.
Therefore a single microliter of patient 1’s blood diluted
into 5 mL of saline would be almost 40,000 infected ery-
throcytes per milliliter of an apparently clear solution.
Our report illustrates that nosocomial transmission can
occur in a tertiary care setting in the United States, despite
healthcare workers’ access to gloves, disposable needles,
intravenous devices, and flushes. The common perception
that flushing practices are not associated with the aspira-
tion of minute amounts of blood contributed to this occur-
rence of nosocomial malaria. Our institution, like many
others, has used such episodes to facilitate change and
refocus on patient safety. The interventions initiated
specifically included retraining of pediatric staff about 1)
no reuse of single use saline flushes, 2) transmission of
bloodborne pathogens with an emphasis on nonviral
pathogens, and 3) removal of multidose vials, including
those with heparin, from pediatric units. Warnings about
the potential risks of reusing saline flush syringes have
been incorporated into institution-wide safety training.
Ongoing rigorous review of healthcare practices and strict
adherence to body and fluid precautions are essential for
minimizing patient exposure to highly infectious
pathogens, even in resource-rich settings.
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